Clinical Trial

Registry of MIUS for Benign Prostatic Obstruction

Study acronym: ReMIUS-BPO
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
This national, multicenter, prospective registry aims to collect standardized perioperative and follow-up data on patients undergoing minimally invasive surgical management for benign prostatic obstruction (BPO) in Turkey. Procedures include transurethral resection of the prostate (TURP), holmium/thulium laser enucleation (HoLEP/ThuLEP), Rezum®, and other contemporary techniques. By prospectively recording patient characteristics, surgical details, and postoperative outcomes in a unified electronic database, the project seeks to provide high-quality real-world evidence to support clinical decision-making, guideline updates, and future hypothesis-driven sub-studies.
Trial Details
NCT Number NCT07159165
Lead Sponsor Ondokuz Mayıs University
Collaborators: Ankara University, Dokuz Eylul University, Erol Olcok Corum Training and Research Hospital, Gazi University, Eskisehir Osmangazi University, Marmara University, Samsun Education and Research Hospital, Cukurova University, Izmir Metropolitan Municipality Esrefpasa Hospital, Tepecik Training and Research Hospital
Conditions Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms
Enrollment 10,000 participants
Start Date 2025-07-01
Primary Completion 2030-07-01 (estimated)
Study Completion 2035-07-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-08